abs163.txt	purpose		to	improve	assessment	of	symptomatic	toxicity	in	cancer	clinical	trialsand	complement	clinician-based	toxicity	reporting		the	us	national	cancerinstitute	developed	a	measurement	system	called	the	patient-reported	outcomesversion	of	the	common	terminology	criteria	for	adverse	events	(pro-ctcae)		theobjective	of	this	study	was	to	examine	the	content	validity	of	pro-ctcae	inpatients	undergoing	radiation	therapy	and	to	establish	anatomic	site-specificitem	sets	for	implementation	in	cancer	research	methods	and	materials		patients	receiving	radiation	to	the	brain		head	and	neck	breast		thorax		abdomen		or	pelvis	were	recruited	during	the	final	week	ofradiation		participants	described	side	effects	qualitatively	and	completedanatomic	site-specific	checklists	indicating	the	presence	or	absence	ofsymptomatic	toxicities	drawn	from	the	pro-ctcae	library		items	endorsed	by	â‰¥20%of	participants	were	selected	for	inclusion		symptomatic	toxicities	describedqualitatively	were	content	analyzed	and	summarized		symptomatic	toxicities	notreflected	in	the	pro-ctcae	item	library	were	tabulated	results		we	conducted	389	interviews	of	patients	receiving	radiation	to	the	brain(n	=	46)		head	and	neck	(n	=	69)		breast	(n	=	134)		thorax	(n	=	30)		abdomen	(n	=27)		female	pelvis	(n	=	36)		or	male	pelvis	(n	=	47)		median	age	was	62	years	62%	were	female		the	53	solicited	pro-ctcae	symptoms	reflected	all	reportedradiation-induced	toxicities	with	the	exception	of	phlegm/mucus	production	andmouth/throat	pain	with	swallowing	in	patients	receiving	head	and	neck	radiation	eye	dryness/irritation	in	patients	undergoing	brain	radiation		and	obstructiveurinary	symptoms	in	men	receiving	pelvic	radiation		the	pro-ctcae	items		skinburns		and		pain		require	greater	specificity	to	adequately	reflect	toxicitiesexperienced	during	radiation	conclusions		pro-ctcae	demonstrates	strong	content	validity	as	a	measure	ofsymptomatic	toxicities	in	patients	receiving	radiation		these	results	provideempirical	support	for	the	definition	of	site-specific	pro-ctcae	item	sets	toassess	the	symptomatic	toxicities	of	radiation	therapy		the	site-specificpro-ctcae	item	sets	developed	herein	are	currently	being	deployed	in	ourdepartment	via	an	electronic	platform	to	capture	treatment-related	toxicity	
